Otter Health has launched with $8 million in seed funding to build an AI-powered healthcare platform designed to help payers and providers manage utilization and quality without relying primarily on traditional prior authorization. The round was co-led by Fika Ventures and Evidenced, with participation from Slow Ventures, Metrodora, CoFound Partners, Layout Ventures, Patient Capital, and Semper Virens.
Otter Health’s EHR-agnostic platform is designed to help healthcare organizations identify low-value and non-evidence-based care decisions in real time. The company aims to replace administrative friction with continuous clinical intelligence that compares care decisions against established evidence and guidelines.
The platform gives payers and providers visibility into care patterns, peer benchmarking, and opportunities for targeted clinician engagement. Otter said the system can help align clinicians, administrators, and medical management teams around care appropriateness while identifying areas to improve quality and reduce unnecessary spending.
Rather than focusing only on services traditionally subject to prior authorization, Otter evaluates a broader range of clinical decisions, including referrals, outpatient procedures, pathway adherence, and care transitions. The company is positioning the platform as a shared framework that gives payers and providers a common view of evidence-based care.
Otter Health said it is already working with multiple payer and provider organizations. The company claims that when traditional prior authorization is removed and replaced with engagement through its platform, non-concordant decisions can be limited to less than 5% while also capturing savings from low-value care that prior authorization may not address.
The company is launching amid increased scrutiny of prior authorization. Citing American Medical Association data, Otter noted that physicians complete nearly 40 prior authorizations per week, while 93% report that the process delays necessary care and 82% say it can cause patients to abandon treatment.
Otter also estimates that more than 60% of low-value healthcare spending occurs outside traditional authorization controls. Its platform is designed to address those areas by continuously evaluating care decisions and surfacing opportunities to reduce unnecessary utilization.
The company was founded by healthcare operators and clinicians with backgrounds in utilization management, clinical quality, and healthcare technology. The new capital will support continued platform development and expansion across payer and provider organizations.
KEY QUOTES:
“Healthcare has spent decades trying to contain spend through administrative friction, creating a system that often puts payers and providers on opposite sides of the same problem. The real goal was never the authorization step itself, but instead was helping organizations deliver more appropriate, evidence-based care at scale. We’re building utilization management and quality around real-time clinical intelligence rather than administrative chokepoints. By giving payers and providers a shared view of the gold standard for quality, we can reduce low-value care, improve outcomes, and create a more collaborative approach to healthcare affordability.”
Keith Florance, Co-Founder And CEO Of Otter Health
“We have a great opportunity to support clinicians in the thousands of decisions they make every day. Creating greater visibility into evidence-based practice through guidance and tools can empower a more proactive and collaborative approach in supporting clinicians to deliver the highest quality care while effectively managing cost and improving access.”
Kate Goodrich, Executive In Residence At Optum, Former Humana Chief Medical Officer And Former Director Of The CMS Center For Clinical Standards And Quality
“Healthcare has spent decades investing in the mechanisms used to control utilization. Otter Health is taking a different approach by creating better visibility into care appropriateness itself. By helping payers and providers operate from the same evidence-based understanding of clinical decisions, the company is creating an alternative to the conflicts that historically defined utilization management. We believe that kind of transparency can reduce waste, improve quality and fundamentally reshape how healthcare organizations manage quality and clinical variation.”
Bryan Sivak, Managing Partner Of Evidenced And Former CTO Of The U.S. Department Of Health And Human Services
